Cargando…
Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia
DNA methyltransferase inhibitors (DNMTis) reexpress hypermethylated genes in cancers and leukemias and also activate endogenous retroviruses (ERVs), leading to interferon (IFN) signaling, in a process known as viral mimicry. In the present study we show that in the subset of acute myeloid leukemias...
Autores principales: | Kogan, Aksinija A., Topper, Michael J., Dellomo, Anna J., Stojanovic, Lora, McLaughlin, Lena J., Creed, T. Michael, Eberly, Christian L., Kingsbury, Tami J., Baer, Maria R., Kessler, Michael D., Baylin, Stephen B., Rassool, Feyruz V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271208/ https://www.ncbi.nlm.nih.gov/pubmed/35759659 http://dx.doi.org/10.1073/pnas.2123227119 |
Ejemplares similares
-
PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers
por: Dellomo, Anna J., et al.
Publicado: (2021) -
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
por: Abbotts, Rachel, et al.
Publicado: (2022) -
Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR
por: Puts, Gemma, et al.
Publicado: (2020) -
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress
por: Doshi, Kshama A., et al.
Publicado: (2016) -
LLL12B, a Novel Small-Molecule STAT3 Inhibitor, Induces Apoptosis and Suppresses Cell Migration and Tumor Growth in Triple-Negative Breast Cancer Cells
por: Pan, Li, et al.
Publicado: (2022)